Literature DB >> 23430186

Localisation and quantification of benzalkonium chloride in eye tissue by TOF-SIMS imaging and liquid chromatography mass spectrometry.

Nicolas Desbenoit1, Isabelle Schmitz-Afonso, Christophe Baudouin, Olivier Laprévote, David Touboul, Françoise Brignole-Baudouin, Alain Brunelle.   

Abstract

Benzalkonium (BAK) chloride is the most commonly used preservative in eye drops. It is generally composed of benzyldimethyldodecylammonium C12 and benzyldimethyltetradecylammonium C14 and is supposed to increase penetration of active compounds. However, numerous studies have reported its toxic effect to ocular surface especially in long-term treatments like against glaucoma, a sight-threatening disease. Albino rabbits were treated with a hyperosmolar solution and a high concentration of BAK solution for 1 month. Enucleated eyes were cryo-sectioned and analysed by mass spectrometry. Mass spectrometry imaging using time-of-flight secondary ion mass spectrometry (TOF-SIMS) has been used to characterize the spatial distribution and to determine the relative quantity of BAK at the surface of rabbit eye sections. Liquid chromatography coupled with mass spectrometry (LC-MS) using a hybrid linear ion trap-Orbitrap® mass spectrometer was used to obtain relative quantification of BAK at the sample surface. TOF-SIMS images of BAK ions indicated a distribution at the ocular surface and in deeper structures. Didecyldimethylammonium (DDMAC), which is used in hospitals as a substitute for BAK, was also detected and showed an accumulation around the eyes. After extraction with acetonitrile and chromatographic separation using a Gemini C18 column and an original elution gradient, the relative quantities of BAK and DDMAC present in the whole eye section surface were determined. This LC-MS method was validated in terms of limits of quantification, linearity, repeatability and reproducibility and its feasibility was evaluated in surgically obtained human samples. Specimens of iris, lens capsule or trabecular meshwork were found with significant levels of BAK and DDMAC, thus confirming the penetration of BAK in deep ocular structures, with potential deleterious effects induced by this cytotoxic compound. The analytical method developed here could therefore be of primary interest in the field of pharmaco-toxicology in order to localise, identify and quantify drugs or xenobiotic compounds present at biological sample surfaces.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23430186     DOI: 10.1007/s00216-013-6811-7

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  12 in total

Review 1.  Benzalkonium chloride and glaucoma.

Authors:  Carol A Rasmussen; Paul L Kaufman; Julie A Kiland
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-08       Impact factor: 2.671

Review 2.  Visualization of metallodrugs in single cells by secondary ion mass spectrometry imaging.

Authors:  Kui Wu; Feifei Jia; Wei Zheng; Qun Luo; Yao Zhao; Fuyi Wang
Journal:  J Biol Inorg Chem       Date:  2017-05-15       Impact factor: 3.358

3.  [Original preparations versus generics--latanoprost: how similar is different?].

Authors:  M A Leitritz; H-P Lipp; B Voykov; F Ziemssen
Journal:  Ophthalmologe       Date:  2015-02       Impact factor: 1.059

4.  Ocular Tolerability of Bimatoprost 0.1 mg/mL Preservative-Free versus Bimatoprost 0.1 mg/mL with Benzalkonium Chloride or Bimatoprost 0.3 mg/mL Preservative-Free in Patients with Primary Open-Angle Glaucoma.

Authors:  Mariaelena Filippelli; Giuseppe Campagna; Nicola Ciampa; Gaetano Fioretto; Roberta Giannini; Pier Franco Marino; Roberto dell'Omo; Ciro Costagliola
Journal:  J Clin Med       Date:  2022-06-19       Impact factor: 4.964

5.  Effect of topical anti-glaucoma medications on late pupillary light reflex, as evaluated by pupillometry.

Authors:  Shakoor Ba-Ali; Birgit Sander; Adam Elias Brøndsted; Henrik Lund-Andersen
Journal:  Front Neurol       Date:  2015-04-29       Impact factor: 4.003

6.  The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells.

Authors:  Sandipan Datta; Christophe Baudouin; Francoise Brignole-Baudouin; Alexandre Denoyer; Gino A Cortopassi
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-04-01       Impact factor: 4.799

7.  Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study.

Authors:  Lutz E Pillunat; Carl Erb; Auli Ropo; Friedemann Kimmich; Norbert Pfeiffer
Journal:  Clin Ophthalmol       Date:  2017-06-02

Review 8.  Preservatives in glaucoma medication.

Authors:  David W Steven; Pouya Alaghband; Kin Sheng Lim
Journal:  Br J Ophthalmol       Date:  2018-07-04       Impact factor: 4.638

9.  Effects of Several Cosmetic Preservatives on ROS-Dependent Apoptosis of Rat Neural Progenitor Cells.

Authors:  Onjeon Ryu; Bo Kyung Park; Minji Bang; Kyu Suk Cho; Sung Hoon Lee; Edson Luck T Gonzales; Sung Min Yang; Seonmin Kim; Pyeong Hwa Eun; Joo Young Lee; Kyu-Bong Kim; Chan Young Shin; Kyoung Ja Kwon
Journal:  Biomol Ther (Seoul)       Date:  2018-11-01       Impact factor: 4.634

10.  Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon.

Authors:  Jie Shen; Marina Bejanian
Journal:  Clin Ophthalmol       Date:  2016-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.